National Institute of Allergy and Infectious Diseases (NIAID): Bacterial Infections trials
The registry lists 13 Bacterial Infections studies with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor. 0 are open to participants now and 5 have results posted.
Phase 1 6Phase 2 3Phase 3 1Phase 4 2No phase 2(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Safety Study of Intravenous Ertapenem in Combination With Zidebactam (WCK 6777)CompletedNCT05645757Phase 1Results posted
- Safety of Intravenous Apramycin in AdultsCompletedNCT05590728Phase 1Results posted
- A Trial to Evaluate the Pharmacokinetics and Safety of AVYCAZ(R) in Combination With AztreonamCompletedNCT03978091Phase 1/2Results posted
- Intravenous Fosfomycin Pharmacokinetics StudyCompletedNCT03910673Phase 1Results posted
- Minocycline Pharmacokinetics (ACUMIN)CompletedNCT03369951Phase 4Results posted
- Optimization of Beta-lactam Dosing in Critically Ill Patients With Cystatin C (OPTIMIZE-GNI)CompletedNCT06709521Phase 4
- Comparative Antibiotic Therapy for Subjects With Pulmonary Infiltrates in the ICUTerminatedNCT00307099Phase 3
- Bacterial Pulmonary Infection in PICUCompletedNCT00271531
- Novel Protective UndergloveCompletedNCT00170586Phase 2
- Strategies to Reduce Transmission of Antimicrobial Resistant Bacteria in Intensive Care Units (STAR*ICU) TrialCompletedNCT00100386Not applicable
- Evaluation of Two Type III GBS Polysaccharide-Tetanus Toxoid Conjugate VaccinesCompletedNCT00008853Phase 1
- Effect of Fluconazole, Clarithromycin, and Rifabutin on the Pharmacokinetics of Sulfamethoxazole-Trimethoprim and Dapsone and Their Hydroxylamine MetabolitesCompletedNCT00000826Phase 1
- A Study to Compare Different Drugs Used to Prevent Serious Bacterial Infections in HIV-Positive ChildrenCompletedNCT00000811Phase 2